INO 240809 9.00C (INO240809C9000) Stock Options, News & Quotes

0.30
-1.68-84.85%

15min DelayClose Aug 8 16:00 ET

0.55High0.21Low

SymbolStock Name

Latest PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Trytosaveabit

Jul 25 15:09

Update

$Inovio Pharmaceuticals (INO.US)$ Reuters· 3 mins ago
Inovio Receives Advanced Therapy Medicinal Product Certificate From European Medicines Agency for Quality and Non-Clinical Data for Lead Candidate Ino-3107

Trytosaveabit

Jul 11 14:04

$Inovio Pharmaceuticals (INO.US)$ Pretty chart! I guess nobody with me? Hehehe

Trytosaveabit

Jul 11 12:18

My post in May wasn’t for this exact info! But it was watch for info on this drug! Hehehe. Just got some PR from another country! Hehehe

$Inovio Pharmaceuticals (INO.US)$ Company Announced That INO-3107, Has Been Designated an Innovative Medicine as Part of the U.K.'s Innovative Licensing and Access Pathway

Trytosaveabit

May 13 15:24

Make note of dates upcoming!

$Inovio Pharmaceuticals (INO.US)$ INOVIO Reports First Quarter 2024 Financial Results and Recent Business Highlights
• BLA submission on track for INO-3107 in second half of 2024; if approved under accelerated approval pathway, could be first non-surgicaltreatment for recurrent respiratory papillomatosis (RRP)
• Planning initiation of confirmatory trial for INO-3107 based on FDA feedback
• Advancing plans for Phase 3 trial of INO-3112 in combination with LOQTORZITM ...

Trytosaveabit

Apr 15 17:41

Ouch! Hehehe

$Inovio Pharmaceuticals (INO.US)$ Inovio Pharmaceuticals Inc - Pricing of an Underwritten Offering of 2.5 Mln Shares of Its Common Stock at an Offering Price of $7.693 per Share